Next 10 |
2024-05-17 14:32:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If the market’s dramatic shifts this year leave you discombobulated, you’re not alone. But, despite widespread overvaluation across a range of tech stocks , plenty of cheap ...
2024-05-13 15:34:34 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Call Transcript Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation...
2024-05-12 03:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-10 15:29:27 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Call Transcript Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation...
A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...
2024-05-01 20:46:08 ET Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Conference Call May 01, 2024 4:30 PM ET Company Participants Andrea Flynn – Vice President and Head-Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Ren...
2024-05-01 16:23:44 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (up...
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference PR Newswire DUBLIN , May 1, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Gl...
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR Newswire – 12% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – On...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This gr...